Literature DB >> 15244387

Thalidomide: tragic past and promising future.

S Vincent Rajkumar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15244387     DOI： 10.4065/79.7.899

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  12 in total

1.  New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin.

Authors:  Joseph I Sirven
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

2.  Over the counter medicines: proceed with caution.

Authors:  Robin E Ferner; Keith Beard
Journal:  BMJ       Date:  2008-03-29

Review 3.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

Review 4.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

5.  The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.

Authors:  Waqas Rehman; Lisa M Arfons; Hillard M Lazarus
Journal:  Ther Adv Hematol       Date:  2011-10

6.  Problems monitoring response in multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

7.  Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease.

Authors:  Belen Lopez-Millan; Rafael Diaz de la Guardia; Heleia Roca-Ho; Carmen M García-Herrero; Jessie R Lavoie; Michael Rosu-Myles; Elena Gonzalez-Rey; Francisco O'Valle; Gabriel Criado; Mario Delgado; Pablo Menendez
Journal:  Exp Mol Med       Date:  2017-02-03       Impact factor: 8.718

8.  Chiral drugs: an overview.

Authors:  Lien Ai Nguyen; Hua He; Chuong Pham-Huy
Journal:  Int J Biomed Sci       Date:  2006-06

9.  Pharmacovigilance for psychiatrists: An introduction.

Authors:  Ravi Philip Rajkumar; George Melvin
Journal:  Indian J Psychiatry       Date:  2014-04       Impact factor: 1.759

10.  Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs.

Authors:  Yohannes Gemechu; David Millrine; Shigeru Hashimoto; Jaya Prakash; Ksenia Sanchenkova; Hozaifa Metwally; Parajuli Gyanu; Sujin Kang; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.